西点药业：2025年前三季度净利润约3315万元

Group 1 - The core viewpoint of the news is that Xidun Pharmaceutical reported a decline in revenue and net profit for the third quarter of 2025 compared to the previous year [1] - For the first three quarters of 2025, the company's revenue was approximately 189 million yuan, representing a year-on-year decrease of 1.89% [1] - The net profit attributable to shareholders was about 33.15 million yuan, reflecting a year-on-year decrease of 2.7% [1] - The basic earnings per share were 0.4333 yuan, which is a decrease of 0.41% year-on-year [1] Group 2 - As of the report date, Xidun Pharmaceutical has a market capitalization of 2.4 billion yuan [2]